In one paragraphArticle in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Esther NdungoCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-9975-7032 Dilara IslamCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Siriphan GonwongArmed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Patricia L MilletichCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7660-3057 Alain AgnememelCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Samandra T DemonsArmed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Marcela F PasettiCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0894-4009 Funding
Mechanisms of protection against shigellosis in childrenR01AI167367 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PASETTI, MARCELA F · 2022 to 2025
$3.8MSerological assays to predict Shigella vaccine efficacyR01AI125841 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PASETTI, MARCELA F · 2016 to 2020
$2.8MNational Institute of Allergy and Infectious Diseases R01 AI125841, R01 AI167367NIAID NIH HHS R01 AI125841NIAID NIH HHS R01 AI167367
6 · The paper itselfAbstract
A safe, effective, and affordable vaccine that can prevent
Indexed as
Antibodies, BacterialDysentery, BacillaryShigella sonneiShigella VaccinesAdolescentAdultAntigens, BacterialFecesFemaleHuman Challenge Trials as TopicHumansImmunoglobulin AImmunoglobulin GMaleMiddle AgedThailandAntibodies, BacterialAntigens, BacterialImmunoglobulin AImmunoglobulin GShigella VaccinesVaccines, Attenuatedantibodiescorrelates of protectionShigellavaccinesWRSS1
Identifiers
PMID42530312
PMCPMC13508790
What OpenQuestion holds
Textmetadata
Read underepoch 390